Investment roundup for Q1 2013

April 16, 2013 | Analyst Insight

Not surprising with the bullish momentum observed (see the July 10, 2012 LRTJ), Oxford Pharmascience secured $8 million in funding from a new investor, Invesco Asset Management. This was...